| 1. | ALA3637831 | F | GSK_TB: Minimum inhibitory concentration against H37Rv stain of Mycobacterium tuberculosis using MABA method | Mycobacterium tuberculosis H37Rv | 50 | ALA3637782 | organism-based format | GSK Tuberculosis Screening |
| 2. | ALA3637832 | F | GSK_TB: Effect of compound calculated as % inhibition at single shot or pIC50 ( pIC50 ATP assay M.bovis) | Mycobacterium bovis | 50 | ALA3637782 | organism-based format | GSK Tuberculosis Screening |
| 3. | ALA3637833 | F | GSK_TB: Inhibition of the intracellular growth of Mycobacterium tuberculosis (pXC50) | Mycobacterium tuberculosis H37Rv | 47 | ALA3637782 | organism-based format | GSK Tuberculosis Screening |
| 4. | ALA3637835 | F | GSK_TB: Activity against non-replicating Mycobacterium tuberculosis (% inhibition) | Mycobacterium tuberculosis H37Rv | 50 | ALA3637782 | organism-based format | GSK Tuberculosis Screening |
| 5. | ALA3637837 | F | GSK_TB: The cytotoxicity against HepG2 cells expressed as IC50 | Homo sapiens | 50 | ALA3637782 | cell-based format | GSK Tuberculosis Screening |
| 6. | ALA3637838 | P | GSK_TB: Kinetic solubility of the compound in phosphate buffered saline at pH 7.4 after 1 hr by CLND method | | 49 | ALA3637782 | small-molecule physicochemical format | GSK Tuberculosis Screening |
| 7. | ALA3637839 | P | GSK_TB: Lipophilicity, log D of the compound at pH 7.4 by ChromlogD analysis | | 50 | ALA3637782 | small-molecule physicochemical format | GSK Tuberculosis Screening |
| 8. | ALA3637840 | P | GSK_TB: AVG_CHROM_LOGP | | 48 | ALA3637782 | small-molecule physicochemical format | GSK Tuberculosis Screening |
| 9. | ALA3832806 | F | AntiMycobacterium tuberculosis activity Replicating form: Average MIC90 (uM) | Mycobacterium tuberculosis | 98 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 10. | ALA3832762 | F | AntiMycobacterium tuberculosis activity Non-Replicating form: Average MIC90 (uM) | Mycobacterium tuberculosis | 98 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 11. | ALA3832763 | F | AntiMycobacterium tuberculosis activity 1-week GAST/Fe MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 12. | ALA3832764 | F | AntiMycobacterium tuberculosis activity 2-week GAST/Fe MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 13. | ALA3832765 | F | AntiMycobacterium tuberculosis activity 1-week 7H9/ADC/Tw MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 14. | ALA3832766 | F | AntiMycobacterium tuberculosis activity 2-week 7H9/ADC/Tw MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 15. | ALA3832767 | F | AntiMycobacterium tuberculosis activity 2-week Alamar Blue 7H9/ADC/Tw MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 16. | ALA3832768 | F | AntiMycobacterium tuberculosis activity 1-week 7H9/glucose/BSA/Tx MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 17. | ALA3832769 | F | AntiMycobacterium tuberculosis activity 2-week 7H9/glucose/BSA/Tx MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 18. | ALA3832770 | F | AntiMycobacterium tuberculosis activity 1-week 7H9/DPPC/cholesterol/BSA/Tx MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 19. | ALA3832771 | F | AntiMycobacterium tuberculosis activity 2-week 7H9/DPPC/cholesterol/BSA/Tx MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |
| 20. | ALA3832772 | F | AntiMycobacterium tuberculosis activity 1-week 7H9/cholesterol/BSA/Tx MIC (uM) | Mycobacterium tuberculosis | 116 | ALA3832761 | organism-based format | MMV Pathogen Box |